Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

433
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
433
Cross-reactivity00:42

Cross-reactivity

31.3K
Overview
31.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

68
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
68
Hybridoma Technology01:31

Hybridoma Technology

15.0K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.0K
Vaccinations01:51

Vaccinations

44.8K
Overview
44.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccination for Patients With Immunosuppression and Altered Immunity: A Workgroup Report from the AAAAI Adverse Reactions to Drugs, Biologics, and Vaccines Committee and the Autoimmunity and Altered Immune Response Committee.

The journal of allergy and clinical immunology. In practice·2026
Same author

Pharmacokinetics and pharmacodynamics of AQST-109 sublingual film in oral allergy syndrome: A phase 2 study.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Stability of epinephrine nasal spray under room temperature, freeze-thaw, and extreme temperature conditions.

The journal of allergy and clinical immunology. In practice·2026
Same author

2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS).

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Delayed diagnoses of x-linked agammaglobulinemia, making the case for newborn screening.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Venom Anaphylaxis.

Immunology and allergy clinics of North America·2026

Related Experiment Video

Updated: Jul 25, 2025

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
05:27

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production

Published on: October 6, 2023

2.8K

Updates and Recent Advances on Venom Immunotherapy.

Michelle L Floyd1, Karla E Adams2, David B K Golden3

  • 142d Medical Group, Maxwell AFB, 300 South Twining Street, Building 760, Montgomery, AL 36112 USA.

Current Treatment Options in Allergy
|June 26, 2023
PubMed
Summary

Venom immunotherapy for Hymenoptera venom allergy has advanced significantly, offering precise, patient-centered care. Recent findings improve diagnosis, safety, and personalized treatment through immunological and genetic insights.

Keywords:
AllergyHymenopteraImmunotherapyInsectStingingVenom

More Related Videos

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

33.7K
Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
09:45

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

Published on: April 21, 2018

13.2K

Related Experiment Videos

Last Updated: Jul 25, 2025

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production
05:27

Author Spotlight: Optimizing Scorpion Venom Extraction for Antivenom Production

Published on: October 6, 2023

2.8K
Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

33.7K
Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
09:45

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

Published on: April 21, 2018

13.2K

Area of Science:

  • Immunology
  • Genetics
  • Allergy Treatment

Background:

  • Venom immunotherapy (VIT) has been a cornerstone for treating Hymenoptera venom allergy since the 1920s.
  • Over a century, advancements in immunology and genetics have refined VIT practices.
  • This review focuses on recent progress in delivering precise, patient-centered venom allergy care.

Purpose of the Study:

  • To review recent advances in venom immunotherapy (VIT).
  • To highlight improvements in diagnosis, safety, and personalized care for venom allergy.
  • To discuss the impact of genetic and immunological research on current VIT practices.

Main Methods:

  • Review of recent scientific literature on venom immunotherapy.
  • Analysis of immunological and genetic research impacting allergy treatment.
  • Synthesis of findings related to diagnostic accuracy, safety, and patient-centered care.

Main Results:

  • VIT modifies both innate and adaptive immune systems.
  • Molecular techniques enhance diagnostic accuracy and safety by identifying specific allergens.
  • Accelerated schedules are safe and improve patient adherence and quality of life.
  • Risk factor elucidation enables personalized immunotherapy and risk profiling.

Conclusions:

  • Venom immunotherapy is a dynamic field with ongoing advancements.
  • Future research should optimize and enhance this life-saving treatment.
  • Personalized and precise care is increasingly achievable through recent progress in VIT.